前列腺特异性膜抗原靶向18F-DCFPyL PET/CT对原发性前列腺癌体积勾画的多重分割方法比较
25例临床局限性高危前列腺癌患者在根治性前列腺切除术前接受18F-DCFPyL PET/CT显像,以组织病理学肿瘤体积为参考标准,比较半自动分割、自适应分割和手动勾画测量前列腺内肿瘤体积的准确性。自适应分割A40%阈值最接近组织病理学肿瘤体积,中位差值为+0.19(IQR,-0.71至+2.01),中位相对差异为+7.6%。
要点
- 自适应分割A40%阈值最接近组织病理学肿瘤体积,中位相对差异为+7.6%。
- A40%、A50%、SUV40%和SUV50%阈值分割的PET肿瘤体积与组织病理学肿瘤体积无显著差异(P>0.05)。
- 手动勾画高估肿瘤体积,中位相对差异为+130%。
核心结论
- 采用自适应分割方法测量前列腺内肿瘤体积和肿瘤-前列腺比值最接近组织病理学肿瘤体积。
- 该信息可能用于指导临床局限性高危前列腺癌男性的初始治疗。
研究设计与样本
- 25例临床局限性高危前列腺癌男性在根治性前列腺切除术前接受18F-DCFPyL PET/CT显像。
- 以前列腺内优势摄取灶为对象,采用半自动分割(SUV30%-SUV70%阈值)、自适应分割(A30%-A70%阈值)和手动勾画测量肿瘤体积及肿瘤-前列腺比值(TPR)。
- 以组织病理学肿瘤体积(TV-Histo)为参考标准,采用配对样本Wilcoxon符号秩检验评估差异,Spearman相关系数评估关联强度。
主要发现
- 中位TV-Histo为2.03 cm3(IQR,1.16-3.36 cm3),中位TPR为10.16%。
- 自适应分割A40%阈值最接近肿瘤体积,中位差值为+0.19(IQR,-0.71至+2.01),中位相对差异为+7.6%。
- A40%、A50%、SUV40%和SUV50%阈值分割的PET肿瘤体积与TV-Histo无显著差异(P>0.05)。
- 两种阈值分割方法中,较高阈值(如SUV60%或SUV70%及A50%-A70%)导致肿瘤体积相对于TV-Histo和TPR被低估,较低阈值(如SUV30%或SUV40%及A30%)导致肿瘤体积相对于TV-Histo和TPR被高估。
- 手动分割高估肿瘤体积,中位差值为+2.49(IQR,0.42-4.11),中位相对差异为+130%。
关键数值与推荐
- 自适应分割A40%阈值的中位差值为+0.19(IQR,-0.71至+2.01),中位相对差异为+7.6%。
- 手动分割的中位差值为+2.49(IQR,0.42-4.11),中位相对差异为+130%。
- A40%、A50%、SUV40%和SUV50%阈值分割的PET肿瘤体积与TV-Histo比较P>0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study aimed to assess the accuracy of intraprostatic tumor volume measurements on prostate-specific membrane antigen-targeted 18F-DCFPyL PET/CT made with various segmentation methods. An accurate understanding of tumor volumes versus segmentation techniques is critical for therapy planning, such as radiation dose volume determination and response assessment. Methods: Twenty-five men with clinically localized, high-risk prostate cancer were imaged with 18F-DCFPyL PET/CT before radical prostatectomy. The tumor volumes and tumor-to-prostate ratios (TPRs) of dominant intraprostatic foci of uptake were determined using semiautomatic segmentation (applying SUVmax percentage [SUV%] thresholds of SUV30%-SUV70%), adaptive segmentation (using adaptive segmentation percentage [A%] thresholds of A30%-A70%), and manual contouring. The histopathologic tumor volume (TV-Histo) served as the reference standard. The significance of differences between TV-Histo and PET-based tumor volume were assessed using the paired-sample Wilcoxon signed-rank test. The Spearman correlation coefficient was used to establish the strength of the association between TV-Histo and PET-derived tumor volume. Results: Median TV-Histo was 2.03 cm3 (interquartile ratio [IQR], 1.16-3.36 cm3), and median TPR was 10.16%. The adaptive method with an A40% threshold most closely determined the tumor volume, with a median difference of +0.19 (IQR, -0.71 to +2.01) and a median relative difference of +7.6%. The paired-sample Wilcoxon test showed no significant difference in PET-derived tumor volume and TV-Histo using A40%, A50%, SUV40%, and SUV50% threshold segmentation algorithms (P > 0.05). For both threshold-based segmentation methods, use of higher thresholds (e.g., SUV60% or SUV70% and A50%-A70%) resulted in underestimation of tumor volumes, and use of lower thresholds (e.g., SUV30% or SUV40% and A30%) resulted in overestimation of tumor volumes relative to TV-Histo and TPR. Manual segmentation overestimated the tumor volume, with a median difference of +2.49 (IQR, 0.42-4.11) and a median relative difference of +130%. Conclusion: Segmentation of intraprostatic tumor volume and TPR with an adaptive segmentation approach most closely approximates TV-Histo. This information might be used to guide the primary treatment of men with clinically localized, high-risk prostate cancer.
引用
- Wang F, Liu C, Vidal I, et al. Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen-Targeted 18F-DCFPyL PET/CT. J Nucl Med. 2024. PMID: 38050147. doi:10.2967/jnumed.123.266005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。